(3) An application must not be accompanied by, or contain any particulars, information, documents, or other material relating to, any research, testing, or teaching that—

(a) relates, in whole or in part, to a psychoactive substance or a psychoactive product; and

(b) involves the use of animals; and

(c) is undertaken in New Zealand or overseas.

(4) Subsection (3) does not apply to any research, testing, or teaching that was undertaken before this Act came into force.

Clause 15

After clause 15(3) (after line 32 on page 16), insert:

(4) The Authority must not take into account, when considering or deciding on an application for a licence, any particulars, information, documents, or other material specified in section 12(3).

Clause 31

After clause 31(2) (after line 25 on page 23), insert:

(3) An application must not be accompanied by, or contain any particulars, information, documents, or other material relating to, any research, testing, or teaching that—

(a) relates, in whole or in part, to a psychoactive substance or a psychoactive product; and

(b) involves the use of animals; and

(c) is undertaken in New Zealand or overseas.

(4) Subsection (3) does not apply to any research, testing, or teaching that was undertaken before this Act came into force.

Clause 35

After clause 35(b) (after line 33 on page 25), insert:

(2) The Authority must not take into account, when considering or deciding on an application for approval of a psychoactive product, any particulars, information, documents, or other material specified in section 31(3).

Explanatory note

This Supplementary Order Paper supercedes Supplementary Order Paper 248 and would amend the Bill to preclude the use of information relating to animal testing of psychoactive products in support of any application under the Bill (including information relating to overseas testing), unless the testing has been undertaken prior to the Bill coming into force. Under the Bill the onus is on an applicant to satisfy the Authority that a psychoactive substance or product “poses no more than a low risk to individuals using it”. The amendments proposed in this Supplementary Order Paper would require an applicant to make their application without reference to any information relating to the results of animal testing. These amendments are intended to discourage manufacturers from conducting, or relying on, future animal testing overseas.

Psychoactive Substances Bill - Amendment paper No 260